Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4

International Immunology

Volumn 27, Issue 11, 2015, Pages 545-553

  Duperray, Alain ^a,b   Barbe, Delphin ^a,b   Raguenez, Gilda ^a,b,i   Weksler, Babette B ^c   Romero, Ignacio A ^d   Couraud, Pierre Olivier ^e,f,g   Perron, Hervé ^h   Marche, Patrice N ^a,b  

^a INSERM   (France)

^b INSTITUTE FOR ADVANCED BIOSCIENCES   (France)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d OPEN UNIVERSITY   (United Kingdom)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT COCHIN   (France)

^g CNRS   (France)

^h GENEURO SA   (Switzerland)

ⁱ University of Mediterranée   (France)

Author keywords

Auto immune disease; Blood brain barrier; Leukocyte adhesion; Retroviral envelope

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; AUTACOID; CYTOKINE; VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOGENOUS RETROVIRUS; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ADHERENCE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS ASSOCIATED RETROVIRUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENVELOPE; BIOSYNTHESIS; BRAIN; CELL LINE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LEUKOCYTE; METABOLISM; VIROLOGY;

BLOOD-BRAIN BARRIER; BRAIN; CELL ADHESION; CELL LINE; CYTOKINES; ENDOGENOUS RETROVIRUSES; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE PRODUCTS, ENV; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MULTIPLE SCLEROSIS; TOLL-LIKE RECEPTOR 4;

EID: 84949187900     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxv025     Document Type: Article

References (40)

1. Perron, H., Geny, C., Laurent, A. et al. 1989. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res. Virol. 140:551.
2. Blond, J. L., Lavillette, D., Cheynet, V. et al. 2000. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74:3321.
3. Belshaw, R., Pereira, V., Katzourakis, A. et al. 2004. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl Acad. Sci. USA 101:4894.
4. Löwer, R., Löwer, J. and Kurth, R. 1996. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl Acad. Sci. USA 93:5177.
5. Feschotte, C. and Gilbert, C. 2012. Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 13:283.
6. Dolei, A. and Perron, H. 2009. The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J. Neurovirol. 15:4.
7. Firouzi, R., Rolland, A., Michel, M. et al. 2003. Multiple sclerosisassociated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J. Neurovirol. 9:79.
8. Rolland, A., Jouvin-Marche, E., Viret, C., Faure, M., Perron, H. and Marche, P. N. 2006. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J. Immunol. 176:7636.
9. Perron, H., Dougier-Reynaud, H. L., Lomparski, C. et al. 2013. Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice. PLoS One 8:e80128.
10. Mi, S., Lee, X., Li, X. et al. 2000. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403:785.
11. Perron, H., Germi, R., Bernard, C. et al. 2012. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult. Scler. 18:1721.
12. Perron, H., Lazarini, F., Ruprecht, K. et al. 2005. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J. Neurovirol. 11:23.
13. Leboyer, M., Tamouza, R., Charron, D., Faucard, R. and Perron, H. 2013. Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface. World J. Biol. Psychiatry 14:80.
14. Mameli, G., Poddighe, L., Mei, A. et al. 2012. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 7:e44991.
15. Holman, D. W., Klein, R. S. and Ransohoff, R. M. 2011. The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 1812:220.
16. Alexander, J. S., Zivadinov, R., Maghzi, A. H., Ganta, V. C., Harris, M. K. and Minagar, A. 2011. Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms. Pathophysiology 18:3.
17. McFarland, H. F. and Martin, R. 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8:913.
18. Correale, J. and Villa, A. 2007. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity 40:148.
19. Weksler, B. B., Subileau, E. A., Perrière, N. et al. 2005. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19:1872.
20. Duperray, A., Languino, L. R., Plescia, J. et al. 1997. Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J. Biol. Chem. 272:435.
21. Gorina, R., Lyck, R., Vestweber, D. and Engelhardt, B. 2014. ß2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier. J. Immunol. 192:324.
22. Ley, K., Laudanna, C., Cybulsky, M. I. and Nourshargh, S. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678.
23. Espevik, T., Latz, E., Lien, E., Monks, B. and Golenbock, D. T. 2003. Cell distributions and functions of Toll-like receptor 4 studied by fluorescent gene constructs. Scand. J. Infect. Dis. 35:660.
24. Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S. and Richter-Dahlfors, A. 2002. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195:559.
25. Ohnishi, T., Muroi, M. and Tanamoto, K. 2003. MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin. Diagn. Lab. Immunol. 10:405.
26. Kremer, D., Aktas, O., Hartung, H. P. and Küry, P. 2011. The complex world of oligodendroglial differentiation inhibitors. Ann. Neurol. 69:602.
27. Danese, S., Dejana, E. and Fiocchi, C. 2007. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J. Immunol. 178:6017.
28. Perron, H., Jouvin-Marche, E., Michel, M. et al. 2001. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 287:321.
29. Cazenave, P. A., Marche, P. N., Jouvin-Marche, E. et al. 1990. V beta 17 gene polymorphism in wild-derived mouse strains: two amino acid substitutions in the V beta 17 region greatly alter T cell receptor specificity. Cell 63:717.
30. Rassa, J. C., Meyers, J. L., Zhang, Y., Kudaravalli, R. and Ross, S. R. 2002. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl Acad. Sci. USA 99:2281.
31. Pegu, A., Qin, S., Fallert Junecko, B. A., Nisato, R. E., Pepper, M. S. and Reinhart, T. A. 2008. Human lymphatic endothelial cells express multiple functional TLRs. J. Immunol. 180:3399.
32. da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S. and Ulevitch, R. J. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276:21129.
33. Frey, E. A., Miller, D. S., Jahr, T. G. et al. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665.
34. Verhasselt, V., Buelens, C., Willems, F., De Groote, D., Haeffner-Cavaillon, N. and Goldman, M. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158:2919.
35. Makó, V., Czúcz, J., Weiszhár, Z. et al. 2010. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1ß, TNF-α, and LPS. Cytometry A 77:962.
36. Kremer, D., Schichel, T., Förster, M. et al. 2013. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann. Neurol. 74:721.
37. Tarassishin, L., Suh, H. S. and Lee, S. C. 2014. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia 62:999.
38. Guijarro-Muñoz, I., Compte, M., Álvarez-Cienfuegos, A., Álvarez-Vallina, L. and Sanz, L. 2014. Lipopolysaccharide activates Tolllike receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes. J. Biol. Chem. 289:2457.
39. Curtin, F., Lang, A. B., Perron, H. et al. 2012. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study. Clin. Ther. 34:2268.
40. Perron, H., Mekaoui, L., Bernard, C., Veas, F., Stefas, I. and Leboyer, M. 2008. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol. Psychiatry 64:1019.